US5516653A
(en)
|
1993-12-28 |
1996-05-14 |
Synaptic Pharmaceutical Corporation |
DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
|
US5545549A
(en)
*
|
1994-02-03 |
1996-08-13 |
Synaptic Pharmaceutical Corporation |
DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
|
US5602024A
(en)
|
1994-12-02 |
1997-02-11 |
Synaptic Pharmaceutical Corporation |
DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
|
US5989920A
(en)
*
|
1994-12-02 |
1999-11-23 |
Synaptic Pharmaceutical Corporation |
Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
|
US5912227A
(en)
*
|
1995-01-27 |
1999-06-15 |
North Carolina State University |
Method of enhancing nutrient uptake
|
US6861053B1
(en)
*
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US6558708B1
(en)
*
|
1995-05-17 |
2003-05-06 |
Cedars-Sinai Medical Center |
Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
|
US7048906B2
(en)
*
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
FR2735983B1
(fr)
|
1995-06-29 |
1997-12-05 |
Centre Nat Rech Scient |
Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
|
AUPO029096A0
(en)
*
|
1996-06-05 |
1996-07-04 |
Crc For Biopharmaceutical Research Pty Ltd |
Npy y2 agonists
|
US6696409B1
(en)
|
1996-06-05 |
2004-02-24 |
Prince Of Wales Medical Research Institute Limited (Powmr Ltd.) |
Neuropeptide Y agonists
|
AU772915B2
(en)
*
|
1996-06-05 |
2004-05-13 |
Prince Of Wales Medical Research Institute Limited |
Neuropeptide Y agonists
|
US6713265B1
(en)
|
1997-06-04 |
2004-03-30 |
Synaptic Pharmaceutical Corporation |
Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
|
US5916869A
(en)
*
|
1997-06-13 |
1999-06-29 |
North Carolina State University |
Method of treating birds in ovo
|
IL138214A0
(en)
*
|
1998-03-09 |
2001-10-31 |
Zealand Pharmaceuticals As |
Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
US6046167A
(en)
*
|
1998-03-25 |
2000-04-04 |
University Of Cincinnati |
Peptide YY analogs
|
EP1189629B1
(en)
|
1999-02-10 |
2010-09-29 |
Curis, Inc. |
Peptide yy (pyy) for treating glucose metabolic disorders
|
US7745216B2
(en)
*
|
1999-02-10 |
2010-06-29 |
Curis, Inc. |
Methods and reagents for treating glucose metabolic disorders
|
US7601691B2
(en)
|
1999-05-17 |
2009-10-13 |
Conjuchem Biotechnologies Inc. |
Anti-obesity agents
|
US6734166B1
(en)
*
|
2000-02-08 |
2004-05-11 |
North Carolina State University |
Method of reducing aluminum levels in the central nervous system
|
AU2007200008B2
(en)
*
|
2000-04-10 |
2008-09-11 |
Cedars-Sinai Medical Center |
Methods for Manipulating Upper Gastrointestinal Transit, Blood Flow, and Satiety, and for Treating Visceral Hyperalgesia
|
DE60140693D1
(en)
|
2000-12-14 |
2010-01-14 |
Amylin Pharmaceuticals Inc |
Ankheiten
|
GB0121709D0
(en)
*
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
MXPA04002751A
(es)
|
2001-09-24 |
2005-09-08 |
Univ Oregon Health & Science |
Modificacion del comportamiento de alimentacion.
|
AU2003201998C1
(en)
|
2002-01-10 |
2012-10-25 |
Imperial Innovations Limited |
Modification of feeding behavior
|
US8058233B2
(en)
*
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
ATE494002T1
(de)
*
|
2002-06-14 |
2011-01-15 |
Amylin Pharmaceuticals Inc |
Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
|
US7166575B2
(en)
*
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
EA008829B1
(ru)
|
2002-12-17 |
2007-08-31 |
Нэстек Фармасьютикал Кампани Инк. |
Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения
|
US7229966B2
(en)
*
|
2002-12-17 |
2007-06-12 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
|
US7186692B2
(en)
|
2002-12-17 |
2007-03-06 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
|
GB0300571D0
(en)
*
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
US7811989B2
(en)
*
|
2003-01-17 |
2010-10-12 |
Ipsen Pharma S.A.S. |
Peptide YY analogs
|
US7780973B2
(en)
*
|
2003-12-15 |
2010-08-24 |
Ethicon Endo-Surgery, Inc. |
Method and device for minimally invasive implantation of biomaterial
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
EP1789440A4
(en)
*
|
2004-02-11 |
2008-03-12 |
Amylin Pharmaceuticals Inc |
REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM
|
BRPI0507594A
(pt)
*
|
2004-02-11 |
2007-07-03 |
Amylin Pharmaceuticals Inc |
polipetìdeos hìbridos com propriedades selecionáveis
|
BRPI0507585A
(pt)
*
|
2004-03-17 |
2007-07-03 |
7Tm Pharmas As |
agonistas seletivos do receptor y2 para intervenções terapêuticas
|
US20090186811A1
(en)
*
|
2004-03-17 |
2009-07-23 |
Thue Schwartz |
Y2 Selective Receptor Agonists for Therapeutic Interventions
|
MXPA06010346A
(es)
*
|
2004-03-17 |
2007-04-23 |
7Tm Pharma As |
Agonistas de receptor selectivo de y2/y4 para intervenciones terapeuticas.
|
NZ555533A
(en)
|
2004-12-13 |
2010-03-26 |
Amylin Pharmaceuticals Inc |
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
PA8660701A1
(es)
*
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
US8283312B2
(en)
*
|
2005-02-04 |
2012-10-09 |
The Research Foundation Of State University Of New York |
Compositions and methods for modulating body weight and treating obesity-related disorders
|
WO2007022123A2
(en)
*
|
2005-08-11 |
2007-02-22 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
GB0504857D0
(en)
*
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
GB0511986D0
(en)
*
|
2005-06-13 |
2005-07-20 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
EP2330125A3
(en)
*
|
2005-08-11 |
2012-12-12 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
AU2005337116A1
(en)
*
|
2005-09-21 |
2007-04-12 |
7Tm Pharma A/S |
Y4 selective receptor agonists for therapeutic interventions
|
JP2009508886A
(ja)
*
|
2005-09-21 |
2009-03-05 |
7ティーエム ファーマ エイ/エス |
治療的介入のためのy2選択性レセプターアゴニスト
|
AU2006297443B2
(en)
|
2005-09-29 |
2010-08-12 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
US20070232537A1
(en)
*
|
2005-12-19 |
2007-10-04 |
Nastech Pharmaceutical Company Inc. |
Intranasal pyy formulations with improved transmucosal pharmacokinetics
|
US20070197445A1
(en)
|
2006-01-18 |
2007-08-23 |
University Of Cincinnati |
Compounds for control of appetite
|
CA2664113C
(en)
|
2006-09-22 |
2013-05-28 |
Merck & Co., Inc. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
US20090099074A1
(en)
*
|
2007-01-10 |
2009-04-16 |
Conjuchem Biotechnologies Inc. |
Modulating food intake
|
CA2682727C
(en)
|
2007-04-02 |
2016-03-22 |
Banyu Pharmaceutical Co., Ltd. |
Indoledione derivative
|
GB0708226D0
(en)
*
|
2007-04-27 |
2007-06-06 |
7Tm Pharma As |
Y-receptor agonists
|
CA2758415C
(en)
|
2008-04-14 |
2019-06-04 |
The General Hospital Corporation |
Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
|
US8299023B2
(en)
|
2008-09-17 |
2012-10-30 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists
|
DK2393828T3
(en)
|
2009-02-03 |
2017-01-23 |
Amunix Operating Inc |
Extended recombinant polypeptides and compositions comprising same
|
WO2011002066A1
(ja)
|
2009-07-02 |
2011-01-06 |
武田薬品工業株式会社 |
ペプチド及びその用途
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
PT2651398T
(pt)
|
2010-12-16 |
2018-03-09 |
Novo Nordisk As |
Composições sólidas compreendendo um agonista de glp-1 e um sal de ácido n-(8-(2-hidroxibenzoil)amino) caprílico
|
EP3406347A3
(en)
|
2012-02-27 |
2019-02-13 |
Amunix Operating Inc. |
Xten conjugate compositions and methods of making same
|
HUE062740T2
(hu)
|
2012-03-22 |
2023-12-28 |
Novo Nordisk As |
GLP-1 peptidek készítményei és elõállításuk
|
SI3068421T1
(sl)
|
2013-11-15 |
2019-08-30 |
Novo Nordisk A/S |
Selektivne spojine PYY in njihova uporaba
|
EP3068795B1
(en)
|
2013-11-15 |
2019-03-06 |
Novo Nordisk A/S |
Hpyy(1-36) having a beta-homoarginine substitution at position 35
|
BR112017025108A2
(pt)
|
2015-06-12 |
2018-07-31 |
Novo Nordisk As |
compostos seletivos de pyy e usos dos mesmos
|
CA3035324A1
(en)
|
2016-08-28 |
2018-03-08 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Method of controlling fungal infections in plants
|
BR112020014624A2
(pt)
|
2018-02-02 |
2020-12-08 |
Novo Nordisk A/S |
Composições sólidas compreendendo agonista de glp-1, sal de ácido n-(8-(2-hidroxibenzoil) amino)caprílico e lubrificante
|
JP2023501478A
(ja)
|
2019-11-13 |
2023-01-18 |
アミュニックス・ファーマシューティカルズ・インコーポレイテッド |
バーコード化されたxtenポリペプチドおよびその組成物、ならびにその作製および使用方法
|